Showing results (141-150 of 178) with videos related to
Sort By:
Pageof 18
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 22, 2021
Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changesPhilip F Halloran, Katelynn Madill-Thomsen, Arezu Z Aliabadi-Zuckermann, et al.Transplantation Direct|March 21, 2020
High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft SurvivalBlanka Mező, Roman Reindl-Schwaighofer, Farsad Eskandary, et al.Transplantation|April 3, 2020
CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft RejectionKonstantin Doberer, Johannes Kläger, Guido A Gualdoni, et al.Scientific Reports|March 11, 2025
Relating the molecular phenotype of ulcerative colitis to the clinical courseKatelynn S Madill-Thomsen, Jeffery M Venner, Denise E Parsons, et al.JCI Insight|October 19, 2018
Exploring the cardiac response to injury in heart transplant biopsiesPhilip F Halloran, Jeff Reeve, Arezu Z Aliabadi, et al.Journal of the American Society of Nephrology : JASN|December 16, 2017
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant RejectionFarsad Eskandary, Heinz Regele, Lukas Baumann, et al.Transplantation|August 15, 2022
Assessing the Relationship Between Molecular Rejection and Parenchymal Injury in Heart Transplant BiopsiesKatelynn S Madill-Thomsen, Jeff Reeve, Arezu Aliabadi-Zuckermann, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 14, 2023
Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammationMatthias Diebold, Hannes Vietzen, Andreas Heinzel, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 18, 2020
Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft lossKieran Halloran, Michael D Parkes, Irina Timofte, et al.Trials|April 9, 2022
Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trialKatharina A Mayer, Klemens Budde, Philip F Halloran, et al.Pageof 18